SB0522 (CH0216)

Find a 2018 Bill:

2018 Regular Session

 

Entitled:

Health Care Providers - Opioid and Benzodiazepine Prescriptions - Discussion of Benefits and Risks

Sponsored by:

Senator Klausmeier

Status:

Approved by the Governor - Chapter 216


Synopsis:Requiring that certain patients be advised of the benefits and risks associated with the prescription of certain opioids and benzodiazepines under certain circumstances; and providing that a violation of the Act is grounds for disciplinary action by the health occupations board that regulates the health care provider who commits the violation.
Analysis:Fiscal and Policy Note (Revised)
All Sponsors:Senators Klausmeier, DeGrange, Middleton, Simonaire, Smith, Young, Zucker, Bates, Kagan, Robinson, Salling, and Muse
Additional Facts:Cross-filed with: HB0653
Bill File Type: Regular
Effective Date(s): October 1, 2018
Committee(s):
Education, Health, and Environmental Affairs  View Committee HearingHealth and Government Operations  View Committee Hearing
Broad Subject(s):Health Occupations
Public Health
Narrow Subject(s):Controlled Dangerous Substances -see also- Drugs; Subst Abus
Discipline
Drugs -see also- Controlled Dangerous Sub; Substance Abuse
Health -see also- Mental and Behavioral Health
Health Occupations -see also- specific health occupations
Minors -see also- Age of Majority; Youth
Notices
Parents and Guardians -see also- Adoption; Child Custody
Patients
Penalties and Sentences -see also- Death Penalty
Records -see also- Land Records; Vital Records
Review Boards
Statutes:Article - Health Occupations
(1-223, 14-404, 16-311, 4-315, 8-316)

How a Bill Becomes Law

Legislative Lingo

Explanation of Floor Motions and Actions


May 9, 2018 1:25 P.M.